If gay men replace clinic-based HIV testing with less
sensitive home tests, the prevalence and incidence of HIV could rise, American researchers
report in the January edition of Sexually
Transmitted Diseases. Because home tests have longer window periods
than laboratory tests, there is a danger that men with recent HIV infection
remain undiagnosed, the model suggests.
In 2012, American
regulators approved the OraQuick
In-Home HIV Test, giving a green light to HIV self-testing at home. In
the United Kingdom, legal restrictions on selling such devices will be
lifted in April.
A systematic
review of studies on self-testing has found it to be acceptable across
a wide variety of populations, but identified few data on linkage to care after
testing positive. One
previous modelling study suggested that if inconsistent condom users used
self-testing to screen sexual partners, it could lead to fewer instances of unprotected
sex and HIV transmission.
The new modelling study was developed on the basis of the
sexual and testing behaviour of gay men in Seattle. Of note, men in this
setting already test quite frequently – the model assumed that at-risk men test on average once or twice a year.
Moreover, broadly in line with trial
results of self-tests and data
comparing different HIV tests, the researchers assumed that modern
clinic-based laboratory tests have a window period of 15 days and detect 100%
of infections after this time. In contrast, the OraQuick In-Home HIV Test was assumed to have a window period of
three months and to detect 91.7% of infections after this time. While this is
the window period stated by the manufacturer, it is quite a conservative
assumption (some infections are likely to be detected prior to three months).
Results
If all HIV testing continues to occur in the clinic, at the
same frequency, then the model produced an estimate of HIV prevalence in gay
men of 18.6%. This figure isn’t far off the observed prevalence in Seattle,
which is around 15%.
However, the model found that HIV prevalence would go up if
men replaced clinic tests with self tests. If half the men did so, prevalence
would be over 23%, and if all men did so, it would rise as high as 27.5%. In
terms of HIV incidence (new infections), it would rise from 1.2 to 1.8% a year
if all men tested at home.
This is because a number of men who have acute (recent) HIV
infection would remain undiagnosed and may continue to have unprotected sex
while they have an exceptionally high viral load.
If men tested more frequently and self tests were used, prevalence would not go up
quite as much, but it wouldn't go down, regardless of how frequently testing
occured. For example, if all men tested twice as often and half of them used
self tests, prevalence would go up to 21%.
The researchers then tested other assumptions about the
window period of self tests. As noted above, if all men tested at home and the
window period is three months, prevalence would be 27.5%. If the window period is
actually two months or one month, prevalence would be around 26% or 21%
respectively – still above current levels.
Again, an increase in the frequency of testing could improve
the situation, but for prevalence to remain at current levels, frequency would
have to be multiplied by 2.6 (if the window period is two months) or 1.2 (if
the window period is one month).
The modelling suggested that delays in linkage to care and
to uptake of HIV treatment could cause additional rises in HIV prevalence, but
the effect would not be as profound as that of the long window period. For
example, if only half the home testers started treatment, prevalence would rise
to 29%. If no home testers started treatment, prevalence would be over 31%.
But low uptake of treatment would have a strong impact on
HIV incidence, which could rise from 1.2% annually to 2.1% or 3.1%.
Conclusions
“Our model suggests that replacement of clinic-based testing
with home-use tests may increase HIV prevalence among Seattle MSM [men who have sex with men], even if
home-use tests allow MSM to test more frequently," the researchers write. “This
potential increase in prevalence seems to be driven primarily by the relatively
long window period of the approved home-use test when compared with available
laboratory based tests, such as NAAT and antigen-antibody combination assays.”
However, they do note some circumstances which their
modelling did not take account of and which could lead to more encouraging
scenarios. Firstly, if self-testing of sexual partners leads to people avoiding
exposure during sex, it could have benefit. Secondly, if self testing leads to
people who do not currently test at all to be tested, it could help lower
prevalence. Finally, the long window periods associated with self tests would
be less of an issue in settings where people test less frequently than in
Seattle – with a longer gap between tests, the chances of a person with
undiagnosed infection having acquired it very recently would be lower.